Boothbay Fund Management’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.28M | Buy |
|
|||||
|
2025
Q1 | – | Hold |
|
|||||
|
2024
Q4 | – | Hold |
|
|||||
|
2024
Q3 | – | Hold |
|
|||||
|
2023
Q4 | – | Hold |
|
|||||
|
2023
Q3 | – | Hold |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $704K | Sell |
|
|||||
|
2022
Q4 | $1.39M | Sell |
|
|||||
|
2022
Q3 | $1.04M | Sell |
|
|||||
|
2022
Q2 | $1.67M | Hold |
|
|||||
|
2022
Q1 | $2.11M | Buy |
|
|||||
|
2021
Q4 | $1.76M | Buy |
|
|||||
|
2021
Q3 | $1.43M | Sell |
|
|||||
|
2021
Q2 | $1.75M | Sell |
|
|||||
|
2021
Q1 | $1.53M | Sell |
|
|||||
|
2020
Q4 | $3.15M | Sell |
|
|||||
|
2020
Q3 | $2.76M | Sell |
|
|||||
|
2020
Q2 | $2.71M | Buy |
|
|||||
|
2018
Q2 | – | Hold |
|
|||||
|
2018
Q1 | – | Hold |
|